| dc.contributor.author |
BHAGWAT S.R. |
|
| dc.contributor.author |
CHOUDHARY K. |
|
| dc.contributor.author |
PANDYA N. |
|
| dc.contributor.author |
SHARMA S. |
|
| dc.contributor.author |
SRIVASTAVA S. |
|
| dc.contributor.author |
KUMAR A. |
|
| dc.contributor.author |
HAJELA K. |
|
| dc.date.accessioned |
2023-03-17T05:35:14Z |
|
| dc.date.available |
2023-03-17T05:35:14Z |
|
| dc.date.issued |
2022 |
|
| dc.identifier.citation |
Molecular Immunology,151114-125 |
en_US |
| dc.identifier.issn |
1615890 |
|
| dc.identifier.uri |
https://dx.doi.org/10.1016/j.molimm.2022.09.001 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/100/40503 |
|
| dc.description.abstract |
Mbl associated serine protease-1 (masp-1) is an abundant enzyme of the lectin complement pathway. Masp-1 cleaves numerous substrates like masp-2, masp-3, c2, c3i, fibrinogen, fxiii and prothrombin. It has thrombin-like specificity and can cleave thrombin substrates. Owing to its high concentration and relaxed substrate specificity, masp-1 has substrates outside the complement system and can influence other proteolytic cascades and physiological processes. The unidentified substrates may assist us to ascertain the role(s) of masp-1. In this study, we used a high-throughput n-terminomics method to identify substrates of masp-1 from human plasma. We have identified 35 putative substrates of masp-1. Among the identified proteins, alpha 2-antiplasmin, alpha-1-acid glycoprotein, antithrombin iii, and siglec-6 were demonstrated to be cleaved by masp-1. We have discussed the physiological relevance of cleavage of these substrates by masp-1. The expression of siglec-6 and masp-1 has been reported in the b cells. Alpha-1-acid glycoprotein cleavage by masp-1 may occur in the acute phase as it is known to be an inhibitor of platelet aggregation, whereas masp-1 triggers platelet aggregation. The cleavage alpha2 antiplasmin by masp-1 implies that masp-1 may be promoting plasmin-mediated fibrinolysis. Our study supports that masp-1 may be implicated in thrombosis as well as thrombolysis. © 2022 elsevier ltd |
en_US |
| dc.language.iso |
English |
en_US |
| dc.publisher |
Elsevier Ltd |
en_US |
| dc.subject |
BIOTINYLATION |
en_US |
| dc.subject |
MASP-1 |
en_US |
| dc.subject |
N-TERMINOMICS |
en_US |
| dc.subject |
PROTEOMICS |
en_US |
| dc.subject |
SERINE PROTEASES |
en_US |
| dc.subject |
SUBSTRATE IDENTIFICATION |
en_US |
| dc.subject.other |
alpha 2 antiplasmin |
en_US |
| dc.subject.other |
antithrombin III |
en_US |
| dc.subject.other |
mannan binding lectin associated serine proteinase |
en_US |
| dc.subject.other |
orosomucoid |
en_US |
| dc.subject.other |
plasmin |
en_US |
| dc.subject.other |
sialic acid binding immunoglobulin like lectin |
en_US |
| dc.subject.other |
streptavidin |
en_US |
| dc.subject.other |
antifibrinolytic agent |
en_US |
| dc.subject.other |
antithrombin III |
en_US |
| dc.subject.other |
fibrinogen |
en_US |
| dc.subject.other |
glycoprotein |
en_US |
| dc.subject.other |
mannan binding lectin associated serine proteinase |
en_US |
| dc.subject.other |
plasmin |
en_US |
| dc.subject.other |
prothrombin |
en_US |
| dc.subject.other |
sialic acid binding immunoglobulin like lectin |
en_US |
| dc.subject.other |
thrombin |
en_US |
| dc.subject.other |
amino terminal sequence |
en_US |
| dc.subject.other |
Article |
en_US |
| dc.subject.other |
autolysis |
en_US |
| dc.subject.other |
biotinylation |
en_US |
| dc.subject.other |
blood clot lysis |
en_US |
| dc.subject.other |
catalysis |
en_US |
| dc.subject.other |
complement lectin pathway |
en_US |
| dc.subject.other |
computer model |
en_US |
| dc.subject.other |
controlled study |
en_US |
| dc.subject.other |
enzyme specificity |
en_US |
| dc.subject.other |
enzyme substrate |
en_US |
| dc.subject.other |
fibrinolysis |
en_US |
| dc.subject.other |
high throughput analysis |
en_US |
| dc.subject.other |
human |
en_US |
| dc.subject.other |
in vitro study |
en_US |
| dc.subject.other |
liquid chromatography-mass spectrometry |
en_US |
| dc.subject.other |
molecular docking |
en_US |
| dc.subject.other |
molecular weight |
en_US |
| dc.subject.other |
plasma |
en_US |
| dc.subject.other |
protein cleavage |
en_US |
| dc.subject.other |
protein expression |
en_US |
| dc.subject.other |
protein expression level |
en_US |
| dc.subject.other |
protein function |
en_US |
| dc.subject.other |
proteomics |
en_US |
| dc.subject.other |
thrombocyte aggregation |
en_US |
| dc.subject.other |
thrombosis |
en_US |
| dc.subject.other |
transamination |
en_US |
| dc.subject.other |
metabolism |
en_US |
| dc.subject.other |
Antifibrinolytic Agents |
en_US |
| dc.subject.other |
Antithrombin III |
en_US |
| dc.subject.other |
Fibrinogen |
en_US |
| dc.subject.other |
Fibrinolysin |
en_US |
| dc.subject.other |
Glycoproteins |
en_US |
| dc.subject.other |
Humans |
en_US |
| dc.subject.other |
Mannose-Binding Protein-Associated Serine Proteases |
en_US |
| dc.subject.other |
Prothrombin |
en_US |
| dc.subject.other |
Sialic Acid Binding Immunoglobulin-like Lectins |
en_US |
| dc.subject.other |
Thrombin |
en_US |
| dc.title |
Identification of substrates of MBL Associated Serine Protease-1 (MASP-1) from human plasma using N-terminomics strategy |
en_US |
| dc.type |
Article |
en_US |